The Medicines (Products for Human Use) (Fees) Regulations 2016, 3

Interpretation of Part 2

In forcesince 11 Feb 2016cited 2×

In this Part—

“EU marketing authorisation” means—

a United Kingdom marketing authorisation granted by the licensing authority under Part 5 (marketing authorisations) of the Human Medicines Regulations;

a marketing authorisation granted by the competent authority of an EEA State other than the United Kingdom in accordance with the 2001 Directive; or

a European Union marketing authorisation; and

“relevant medicinal product” means a medicinal product for human use to which the provisions of the 2001 Directive apply.